Author:
Stary J, ,Jabali Y,Trka J,Hrusak O,Gajdos P,Hrstkova H,Sterba J,Blazek B,Hak J,Prochazkova D,Cerna Z,Smisek P,Sedlacek P,Vavra V,Mihal V,Hrodek O
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference4 articles.
1. Schrappe M, Reiter A, Ludwig WD, Harbott J, Zimmermann M, Hiddemann W et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL Study Group. Blood 2000; 95: 3310–3322.
2. Stary J, Gajdos P, Hrstkova H, Blazek B, Slavik Z, Mihal V et al. Treatment of Czech children with acute lymphoblastic leukemia: a report of the Czech Working Group for Pediatric Hematology. Med Pediatr Oncol 2002; 39: 125–127.
3. Möricke A, Reiter A, Zimmermann M, Gadner H, Stanulla M, Dördelmann M, et al. German-Austrian-Swiss ALL Study Group. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patiens enrolled in the trial ALL-BFM 95. Blood 2008; 111: 4477–4489.
4. Conter V, Valsecchi MG, Silvestri D, Campbell M, Dibar E, Magyarosy E et al. Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial. Lancet 2007; 369: 123–131.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献